| Financial Year |
September 30 2019 |
| Monetary Funds |
84,606,003.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,877,480.22 |
| Accounts Receivable |
43,328,863.19 |
| Advances to Suppliers |
254,566,644.54 |
| Other Receivables |
1,739,899,779.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
19,305,007.03 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
521,683.29 |
| Total Current Assets |
2,145,105,461.59 |
| Available-for-Sale Financial Asset |
413,692.76 |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
39,915,226.31 |
| Investment Properties |
-- |
| Fixed Assetes |
14,889,902.28 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,249,544.33 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
672,329.47 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
158,659,244.02 |
| Sub-Total of Non-Current Assets |
215,799,939.17 |
| Total Assets |
2,360,905,400.76 |
| Short-Term Loans |
265,954,347.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
867,920.00 |
| Accounts Payable |
28,681,260.43 |
| Accounts Received In Advance |
22,616,523.95 |
| Employee Compensation Payable |
3,918,857.66 |
| Taxes Payable |
1,645,471.91 |
| Interest Payable |
41,324,143.12 |
| Dividend Payable |
-- |
| Other payables |
102,836,492.76 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
426,520,874.34 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,501,472,002.71 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,501,472,002.71 |
| Total Liabilities |
1,927,992,877.05 |
| Paid-In Capital(Or Share Stock) |
1,464,328,399.00 |
| Capital Surplus |
1,011,599,017.44 |
| Surplus Reserve |
115,472,292.19 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,174,407,773.19 |
| Minority Stockholder's Interest |
15,920,588.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
416,991,935.44 |
| Owner's Equity（Stockholder's Equity） |
432,912,523.71 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,360,905,400.76 |
